Abstract
Commentary The cause and pathophysiology of mood and psychotic disorders, including unipolar depression, bipolar disorder, and schizophrenia, is variable. Several scenarios have been proposed to explain the development of psychoses, one of which is mitochondrial dysfunction (mitochondrial mood and psychotic disorders) [1,2]. Impaired mitochondrial pathways, which may be associated with mood and psychotic disorders, include the respiratory chain (Figure 1) [1,3], the pyruvate-dehydrogenase complex, the 2-ketoglutarate dehydrogenase [4], and the polyol pathway [5]. Disturbance of the respiratory chain is the most frequent cause of mitochondrial mood and psychotic disorders. Mood and psychotic disorders in patients with mitochondrial disorders may be the sole manifestation, or one among other manifestations, of a mitochondrial disorder. Mood and psychotic disorders may be the dominant feature of the phenotype or a collateral finding, and may occur in syndromic as well as non-syndromic [5,6] mitochondrial disorders. A recent study, published in this journal [1], aimed to assess psychiatric abnormalities in mitochondrial disorders with a proven mtDNA defect [1]. Twelve patients had a syndromic mitochondrial disorder (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), myoclonic epilepsy with ragged red fibers (MERRF), neuropathy, ataxia, and retinitis pigmentosa (NARP), progressive external ophthalmoplegia (PEO), Kearns-Sayre syndrome (KSS)) and seven patients had a non-syndromic mitochondrial disorder. The frequency of psychiatric diagnoses among these patients was reported to be 47% [1]. Psychiatric conditions may be even more common in other studies and include major depression, agoraphobia and/or panic disorder, generalized anxiety disorder, social anxiety disorder, or psychotic syndromes [7]. The medication these patients took at inclusion was provided for only nine patients. Among these drugs, however, several are reported to be mitochondriontoxic. Two patients were medicated with valproic acid, two
Highlights
Commentary The cause and pathophysiology of mood and psychotic disorders, including unipolar depression, bipolar disorder, and schizophrenia, is variable
Two patients were medicated with valproic acid, two Correspondence: fifigs1@yahoo.de KAR, Postfach 20, Vienna 1180, Austria with quetiapine, and one each with carbamazepine, atorvastatin, mirtazepine, metformin, and trazodone [1]
The study did not address whether, and to what degree, anti-psychotic or other medication may worsen the underlying defect due to mitochondrion-toxicity of the applied medication [1]. This is important since deterioration of the clinical presentation may be due to worsening of the underlying metabolic defect, and due to mitochondriontoxicity of the applied anti-psychotic medication
Summary
Commentary The cause and pathophysiology of mood and psychotic disorders, including unipolar depression, bipolar disorder, and schizophrenia, is variable. A recent study, published in this journal [1], aimed to assess psychiatric abnormalities in mitochondrial disorders with a proven mtDNA defect [1]. Two patients were medicated with valproic acid, two Correspondence: fifigs1@yahoo.de KAR, Postfach 20, Vienna 1180, Austria with quetiapine, and one each with carbamazepine, atorvastatin, mirtazepine, metformin, and trazodone [1].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.